INJECTABLE DRUG DELIVERY MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: MD-R-2024-11-27-124502 |   Healthcare

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Injectable Drug Delivery Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL INJECTABLE DRUG DELIVERY MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL INJECTABLE DRUG DELIVERY MARKET

7.1 GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Baxter International, Inc.

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Becton, Dickinson and Company

16.3 Gerresheimer Ag

16.4 Pfizer, Inc.

16.5 Eli Lilly and Company

16.6 Sandoz (A Division of Novartis Ag)

16.7 Terumo Corporation

16.8 Teva Pharmaceutical Industries Ltd.

16.9 SHL Group

16.10 Schott AG

16.11 West Pharmaceutical Services, Inc.

16.12 Insulet Corporation

16.13 Elcam Medical

16.14 Ypsomed AG

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Type
Devices
 o Conventional Injection Devices
   o By Material
     o Glass
     o Plastic
   o By Product
     o Fillable Syringes
     o Prefilled Syringes
   o By Usability
     o Reusable Injection Devices
     o Disposable Injection Devices
 o Self-Injection Devices
   o Needle-Free Injectors
     o By Product
       o Fillable Needle-Free Injectors
       o Prefilled Needle-Free Injectors
     o By Technology
       o Jet-Based Needle-Free Injectors
       o Spring-Based Needle-Free Injectors
       o Laser-Powered Needle-Free Injectors
       o Vibration-Based Needle-Free Injectors
     o By Usability
       o Reusable Needle-Free Injectors
       o Disposable Needle-Free Injectors
   o Autoinjectors
     o By Product
       o Fillable Autoinjectors
       o Prefilled Autoinjectors
     o By Technology
       o Automated Autoinjectors
       o Manual Autoinjectors
     o By Design
       o Standardized Autoinjectors
       o Customized Autoinjectors
     o By Usability
       o Reusable Autoinjectors
       o Disposable Autoinjectors
   o Pen Injectors
     o By Product
       o Single-Chambered Pen Injectors
       o Dual-Chambered Pen Injectors
     o By Design
       o Standard Pen Injectors
       o Customized Pen Injectors
     o By Usability
      o Reusable Pen Injectors
       o Disposable Pen Injectors
   o Wearable Injectors
   o Other Devices
Formulations
 o Conventional Drug Delivery formulations
   o Solutions
   o Reconstituted/Lyophilized formulations
   o Suspensions
   o Emulsions
 o Novel Drug Delivery formulations
   o Colloidal Dispersions
     o Niosomes
     o Liposomes
     o Polymeric/Mixed Micelles
     o Nanoparticles
       o Solid-Lipid Nanoparticles
       o Nanosuspensions
       o Nanoemulsions
   o Microparticles
     o Microspheres
     o Microcapsules
 o Long-Acting Injection formulations

By Formulation Packaging
Ampules
Vials
Cartridges
Bottles

By Therapeutic Usage Pattern
Auto-immune diseases
  o Rheumatoid Arthritis
  o Multiple Sclerosis (Ms)
  o Crohn’s Disease
  o Psoriasis
  o Other Autoimmune Diseases
Hormonal Disorders
  o Diabetes
  o Anemia'
  o Reproductive Health Disease
  o Antithrombotic/Thrombolytic Therapy
  o Osteoporosis
  o Growth Hormone Deficiency (Ghd)
Orphan Diseases
Oncology
Other Therapeutic Applications
  o Pain Management
  o Allergies
  o Aesthetic Treatment
  o Hepatitis C
  o Hemophilia

By Usage Pattern
Curative Care
Immunization
Other Usage Pattern

By Site of Administration
Skin
Circulatory/Musculoskeletal
Organs
Central Nervous System

By Distribution Channel
Hospitals
Retail Pharmacy Stores

By Facility of Use
Hospitals & Clinics
Home Care Settings
Other Facilities of Use

Companies

Baxter International, Inc.
Becton, Dickinson and Company
Gerresheimer Ag
Pfizer, Inc.
Eli Lilly and Company
Sandoz (A Division of Novartis Ag)
Terumo Corporation
Teva Pharmaceutical Industries Ltd.
SHL Group
Schott AG
West Pharmaceutical Services, Inc.
Insulet Corporation
Elcam Medical
Ypsomed AG

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.